NBSE
NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE
Delisted
NBSE was delisted on the 10th of May, 2024.
19 hedge funds and large institutions have $177K invested in NeuBase Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
19
Holding in Top 10
1
Calls
–
Puts
–
Top Sellers
1 | -$27.7K | |
2 | -$15.6K | |
3 | -$12.2K | |
4 |
BlackRock
New York
|
-$62 |
5 |
GWMIA
Global Wealth Management Investment Advisory
Fort Lauderdale,
Florida
|
-$9 |